Aristo Pharma Nordic ApS — Credit Rating and Financial Key Figures
CVR number: 32328768
Tonsbakken 16, 2740 Skovlunde
info.nordic@aristo-pharma.dk
tel: 70707982
www.amnealnordic.com
Income statement (kEUR)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 469.74 | 805.03 | 789.37 | 717.13 | 326.65 |
| Employee benefit expenses | - 597.92 | - 691.50 | - 720.96 | - 657.23 | - 295.70 |
| Total depreciation | -3.37 | -6.02 | -2.67 | -2.87 | -2.56 |
| EBIT | - 131.55 | 107.50 | 65.75 | 57.02 | 28.39 |
| Other financial income | 1.03 | 4.34 | 0.81 | 8.04 | 2.85 |
| Other financial expenses | - 155.54 | -49.72 | -21.22 | -13.54 | -5.39 |
| Pre-tax profit | - 286.05 | 62.13 | 45.33 | 51.52 | 25.85 |
| Net earnings | - 286.05 | 62.13 | 45.33 | 51.52 | 25.85 |
Assets (kEUR)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 0.37 | ||||
| Intangible assets total | 0.37 | ||||
| Machinery and equipment | 6.53 | 3.79 | 2.81 | 6.22 | 3.70 |
| Tangible assets total | 6.53 | 3.79 | 2.81 | 6.22 | 3.70 |
| Investments total | |||||
| Non-current loans receivable | 6.72 | ||||
| Non-current other receivables | 82.23 | ||||
| Long term receivables total | 82.23 | 6.72 | |||
| Inventories total | |||||
| Current trade debtors | 35.27 | 33.80 | 1.12 | ||
| Current amounts owed by group member comp. | 442.59 | 190.08 | 418.70 | 1 302.45 | 1 848.59 |
| Prepayments and accrued income | 8.39 | 8.27 | 6.71 | 7.97 | |
| Current other receivables | 54.25 | 79.94 | 10.24 | 17.49 | 25.76 |
| Short term receivables total | 540.50 | 312.08 | 436.77 | 1 327.91 | 1 874.35 |
| Cash and bank deposits | 131.13 | 9.46 | 55.85 | 41.93 | 79.01 |
| Cash and cash equivalents | 131.13 | 9.46 | 55.85 | 41.93 | 79.01 |
| Balance sheet total (assets) | 760.39 | 332.04 | 495.44 | 1 376.07 | 1 957.42 |
Equity and liabilities (kEUR)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 14.43 | 11.43 | 14.43 | 14.43 | 14.43 |
| Retained earnings | -1 064.28 | -1 347.34 | 0.95 | 46.29 | 97.81 |
| Profit of the financial year | - 286.05 | 62.13 | 45.33 | 51.52 | 25.85 |
| Shareholders equity total | -1 335.90 | -1 273.78 | 60.72 | 112.25 | 138.09 |
| Provisions | 160.00 | 102.00 | |||
| Non-current owed to group member | 1 351.95 | 1 207.38 | 397.42 | 1 085.59 | 1 765.00 |
| Non-current other liabilities | 14.76 | 68.20 | |||
| Non-current liabilities total | 1 366.70 | 1 275.57 | 397.42 | 1 085.59 | 1 765.00 |
| Current loans from credit institutions | 0.04 | 0.02 | 0.03 | ||
| Current trade creditors | 346.23 | 60.07 | 11.45 | 80.84 | 9.14 |
| Current owed to group member | 153.28 | 47.73 | |||
| Other non-interest bearing current liabilities | 70.08 | 120.45 | 8.17 | 97.38 | 45.16 |
| Accruals and deferred income | 17.64 | ||||
| Current liabilities total | 569.59 | 228.25 | 37.30 | 178.24 | 54.33 |
| Balance sheet total (liabilities) | 760.39 | 332.04 | 495.44 | 1 376.07 | 1 957.42 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.